Drugs / adipose derived stem cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05610865 | Nov 2020 → Dec 2025 overdue | diabetes mellitus, ulcer of lower limbs | University of the Punjab | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adipose derived stem cells | “uncultured adipose derived stromal vascular fraction (SVF) and cultured adipose derived stem cells (ASCs) both supplemented with platelet rich plasma (PRP) to treat chronic...” NCT05610865 ↗ |
| Known as | ASCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05610865 ↗ |
| Modality | Cell therapy | “Cultured ASCs along PRP were mixed, transferred to 1 cc syringes and injected / cm2 intradermally at the border zone \& inside of wound surface bed.” NCT05610865 ↗ |